School of Medicine
Showing 81-90 of 627 Results
-
Emily Chan
Associate Professor of Pathology (Clinical Pathology)
BioDr. Chan is an Associate Professor of Pathology at Stanford University. She completed her MD, PhD at New York University and Anatomic Pathology residency with subspecialty Genitourinary Pathology training at University of California-San Francisco (UCSF). She is AP board-certified. Dr. Chan was a GU attending at UCSF for five years before joining Stanford to lead the Genitourinary Pathology Service and Fellowship. She has successfully mentored numerous trainees in projects, publications, and career planning. Dr. Chan has co-authored more than 70 peer-reviewed research publications and has a particular interest in integrating molecular testing in diagnostic pathology, as well as recognition of prostate cancer architectural patterns than can help with prognosis and treatment decision making.
-
Anne Lynn S. Chang, MD
Professor of Dermatology
Current Research and Scholarly InterestsMy two main research interests are:
1) To better understand and treat patients with aggressive basal and squamous cell carcinomas
2) To better understand the genetic and epigenetic mechanisms of healthy human skin aging and to translate these insights into better care of skin diseases enriched in older patients, particularly skin cancer and rosacea -
Howard Y. Chang, MD, PhD
Virginia and D. K. Ludwig Professor of Cancer Research, Professor of Genetics and, by courtesy, of Pathology
Current Research and Scholarly InterestsOur research is focused on how the activities of hundreds or even thousands of genes (gene parties) are coordinated to achieve biological meaning. We have pioneered methods to predict, dissect, and control large-scale gene regulatory programs; these methods have provided insights into human development, cancer, and aging.
-
Greg Charville, MD, PhD
Associate Professor of Pathology
BioDr. Charville has a special interest in the diagnosis of rare tumors that derive from bone and soft tissues, including muscle, fat, blood vessels, cartilage, and other connective tissues. He also specializes in the classification and study of diseases related to the gastrointestinal and hepatopancreatobiliary systems.
Dr. Charville particularly enjoys working alongside Stanford's excellent physicians-in-training to classify the most diagnostically challenging cases in collaboration with pathologists from around the world, bringing to bear cutting-edge techniques for comprehensive histologic and molecular characterization in each case. This experience serves as the inspiration for laboratory-based investigation of the molecular underpinnings of human disease, focusing on genetic and epigenetic mechanisms of neoplasia and the translation of these mechanistic insights into novel diagnostic and predictive biomarkers. -
James K. Chen
Jauch Professor and Professor of Chemical and Systems Biology, of Developmental Biology and of Chemistry
Current Research and Scholarly InterestsOur laboratory combines chemistry and developmental biology to investigate the molecular events that regulate embryonic patterning, tumorigenesis, and sperm development. We are currently using genetic and small-molecule approaches to study the molecular mechanisms that sustain stem-like cancer cells or promote spermiogenesis. We are also developing new technologies for optically controlling developmental signaling proteins.
-
Michelle M. Chen, MD, MHS, FACS
Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS)
BioDr. Chen is a fellowship-trained head and neck surgical oncologist with a board certification in otolaryngology and an assistant professor with the Stanford School of Medicine Department of Otolaryngology.
Her practice focuses on the treatment of cancers that affect the head and neck. She has received additional training in microvascular reconstruction and transoral robotic surgery.
Dr. Chen has an active lab involved in head and neck cancer health services research and her work has appeared in numerous journals, including The Journal of the American Medical Association, Cancer, Journal of the National Cancer Institute, and Journal of Clinical Oncology. She has also authored chapters in textbooks on head and neck cancer treatment.
Dr. Chen is a member of the American Academy of Otolaryngology—Head & Neck Surgery (AAOHNS) and the American Head & Neck Society. -
Yiyun Chen
Postdoctoral Scholar, Stanford Cancer Institute
BioYiyun Chen is a computational cancer immunologist whose interdisciplinary training spans structural biology, computational genomics, and cancer immunotherapy. During her doctoral training at HKUST, she developed multi-omic frameworks to decode the molecular landscape of brain tumors, gastric cancer, and B cell lymphoma — including the discovery of a tumor-associated monocyte population in the glioma microenvironment that drives mesenchymal transformation through the FOSL2-EREG/AREG-EGFR signaling axis.
As a postdoctoral fellow in the Crystal Mackall Laboratory at Stanford Cancer Institute, she extended this focus to the co-evolution of glioma and the immune system during CAR T cell therapy, uncovering multiple mechanisms of acquired resistance: anti-CAR humoral and cellular immunity, proinflammatory-to-immunosuppressive phenotypic shifts in macrophages, and tumor antigen escape. Her future research program will build an AI-powered platform that integrates longitudinal single-cell and spatial transcriptomics to model tumor-immune co-evolution in silico — constructing patient-level digital twins that simulate treatment trajectories, predict resistance, and identify real-time monitoring biomarkers.
